Cancer drug discovered in Indiana to power Indy Novartis plant
Novartis says its $100 million cutting-edge Indianapolis facility to manufacture the new nuclear medicine Pluvicto is on the cusp of opening—and the drug’s genesis belongs to Purdue University’s Dr. Philip Low, a serial entrepreneur and industry icon. ... Read More
